(Phys.org) —A multidisciplinary team of scientists from UCLA and Stanford University has used a naturally occurring nanoparticle called a vault to create a novel drug delivery system that could lead to advances in the treatment ...
Bio & Medicine
Aug 22, 2014
0
1
Inasmuch as therapeutic options against coronavirus have been focused mainly on blocking the interaction between its spike protein and the ACE2 receptor on host cells, SARS-CoV-2 has several additional critical proteins that ...
Scientists at The Scripps Research Institute have used a powerful new chemical-screening method to find compounds that inhibit the activity of human immunodeficiency virus (HIV), the virus that causes AIDS. Unlike existing ...
Biochemistry
Jun 13, 2012
0
0
The first few hours to days following exposure to human immunodeficiency virus (HIV) can be of critical importance in determining if infection occurs in a patient. But the low numbers of viruses and infected cells at this ...
Mathematics
May 31, 2013
0
0
(Phys.org) —In a study published in today's issue of Nature Communications, researchers from FIU's Herbert Wertheim College of Medicine describe a revolutionary technique they have developed that can deliver and fully release ...
Bio & Medicine
Apr 17, 2013
0
0
In an advance toward eliminating pockets of infection in the brain that help make HIV disease incurable, scientists report the development of new substances that first plug the biological vacuum cleaner that prevents anti-HIV ...
Biochemistry
Oct 12, 2011
0
0
(PhysOrg.com) -- Scientists at the University of Toronto and Stanford and Columbia Universities have developed a way to measure the action and function of candidate prescription drugs on human cells, including the response ...
Biochemistry
May 9, 2011
0
0
The human immunodeficiency virus (HIV) can contain dozens of different mutations, called polymorphisms. In a recent study an international team of researchers, including MU scientists, found that one of those mutations, called ...
Biochemistry
Sep 13, 2012
1
0
A collaborative team led by a Northeastern University professor may have altered the way we look at drug development for HIV by uncovering some unusual properties of a human protein called APOBEC3G (A3G).
Biochemistry
Nov 25, 2013
0
0
Successful results of a University of Liverpool-led trial that utilised nanotechnology to improve drug therapies for HIV patients has been presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in ...
Bio & Medicine
Feb 21, 2017
0
32
